XIENCE™ Stent is the DES that delivers consistently outstanding short- and long-term patient outcomes.2
In fact XIENCE™ Stent consistently has the lowest rate of late and very late stent thrombosis (ST)—not only a year but a decade after the intervention—providing evidence that the XIENCE™ Stent's unparalleled patient outcomes last far beyond the intervention.1
Long-term restenosis rates are also low, as shown by freedom from clinically driven target lesion revascularization (CD-TLR) at 7 years.9
XIENCE™ Stent data shows consistent device success—and in all types of patients and lesions.
XIENCE™ Stent has been shown to improve patient quality of life out to 3 years with 80% of patients reporting that they were angina free.
MAT-2101782 v1.0
You are about to enter an Abbott country- or region-specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions
Do you wish to continue and enter this website?
MAT-2305078 v1.0